Ceftazidime and Dextrose (B. Braun Medical Inc.)


Welcome to the PulseAid listing for the Ceftazidime and Dextrose drug offered from B. Braun Medical Inc.. This Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: B. Braun Medical Inc.
NON-PROPRIETARY NAME: CEFTAZIDIME
SUBSTANCE NAME: CEFTAZIDIME
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-06-13
END MARKETING DATE: 0000-00-00


Ceftazidime and Dextrose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCeftazidime and Dextrose from B. Braun Medical Inc.
LABELER NAME: B. Braun Medical Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/50mL)
START MARKETING DATE: 2011-06-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0264-3143_f54834fc-42a7-4894-9ce8-97560a10be03
PRODUCT NDC: 0264-3143
APPLICATION NUMBER: NDA050823

Other CEFTAZIDIME Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Ceftazidime and Dextrose
Hospira, Inc.TAZICEF
Sagent PharmaceuticalsCeftazidime
Sandoz IncCeftazidime
WG Critical Care, LLCCeftazidime